Illumina and Hamilton Robotics are expanding their ongoing partnership to collaborate on developing and promoting the VeriSeq NIPT Solution for high-throughput noninvasive prenatal testing (NIPT). This automated, next-generation sequencing (NGS) workflow features a six-step process for up to 48 or 96 samples at a time that delivers results in approximately 1 day. It combines Illumina’s NGS technology with Hamilton Robotics’ VeriSeq NIPT Microlab STAR automated workstation, which is pre-configured to work with Illumina’s NIPT assay reagents, consumables, and analysis software during plasma isolation, library preparation, quantification, and pooling of maternal whole blood samples. Altogether, the VeriSeq NIPT Solution provides a whole-genome sequencing workflow that does not involve polymerase chain reaction. According to Hamilton Robotics, this approach has been shown to provide one of the lowest test failure rates among NIPT technologies.